Skip to content

Author

David P. Salmon

We have 2 of 75 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Statistical efficiency of outcome measures for secondary prevention trials in Alzheimer's disease: Evidence from the A4 trial

Abstract INTRODUCTION Secondary prevention trials targeting preclinical Alzheimer's disease (AD) require clinical outcome assessments (COAs) that are sensitive to subtle decline that might be found in the cognitively unimpaired population typically enrolled in these trials. The recently completed Anti‐Amyloid Treatment...

Jasmin A. Duehring, Howard H. Feldman, D. Salmon et al. · 0 citations
Jul 2026

Neurofibrillary tangle distribution in posterior cortical atrophy and typical early-onset Alzheimer's Disease

PCA is associated with a distribution of NFT pathology that coincides with early predominant visuospatial impairment in EOAD generally and may moderate degree of visuospatial impairment in EOAD regardless of clinical syndrome.

Denis S. Smirnov, Sophie M. Dickinson, Melanie F Estrella et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.